[1] 王贵强,王福生,成军等.慢性乙型肝炎防治指南(2015年版)[J].中华实验和临床感染病杂志(电子版),2015,17(5):570-589. [2] Wai CT,Greenson JK,Fontana RJ,et al.A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C[J].Hepatology,2003,38(2):518-26. [3] 李春娜,周耀勇,洪仲思,等.B超引导下经皮肝穿刺345例安全性评价[J].临床医学工程,2013,20(4):394-395. [4] 中华医学会肝病学分会.病毒性肝炎防治方案[J].中华传染病杂志,2001,19(1):56-62. [5] 郜玉峰,邹桂舟,叶珺,等.431例慢性乙型肝炎病毒感染者临床指标与肝脏病理分析[J].中华疾病控制杂志,2014,18(10):964-967. [6] 严海明,申淑怡,叶一农,等.E抗原阴性慢性乙型肝炎临床特征及血清学指标的分析[J].热带医学杂志,2013,13(7):878-879+886. [7] Jin W,Lin Z,Xin Y,et al.Diagnostic accuracy of the aspartate aminotransferase-to-platelet ratio index for the prediction of hepatitis B-related fibrosis:a leading meta-analysis[J].BMC Gastroenterol,2012,12(3):14-14. [8] Shoaei SD,Sali S,Karamipour M,et al.Non-Invasive Histologic Markers of Liver Disease in Patients With Chronic Hepatitis B[J].Hepatitis Monthly,2014.14(2):e14228. [9] R Jan,NA Khan.The 22nd Conference of the Asian Pacific Association for the Study of the Liver[J].Hepatol Int,2012,6(1):1-21. [10] Alam S,Ahmad N,Mustafa G,et al.Evaluation of normal or minimally elevated alanine transaminase,age and DNA level in predicting liver histological changes in chronic hepatitis B[J].Liver Int,2011,31(6):824-830. [11] EASL clinical practice guidelines:Management of chronic hepatitis B virus infection[J].J Hepatol,2012,57(1):167-185. [12] Wong GL,Wong VW,Choi PC,et al.Clinical Factors Associated With Liver Stiffness in Hepatitis B e Antigen-Positive Chronic Hepatitis B Patients[J].Clinical Gastroenterology and Hepatology,2009,7(2):227-233. |